ID   AREL1_HUMAN             Reviewed;         823 AA.
AC   O15033; B4E2C7; Q7LDY1; Q8IYY9;
DT   29-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   29-MAR-2005, sequence version 3.
DT   28-JAN-2026, entry version 177.
DE   RecName: Full=Apoptosis-resistant E3 ubiquitin protein ligase 1 {ECO:0000305};
DE            EC=2.3.2.26 {ECO:0000269|PubMed:23479728, ECO:0000269|PubMed:25752577};
DE   AltName: Full=Apoptosis-resistant HECT-type E3 ubiquitin transferase 1 {ECO:0000303|PubMed:23479728};
GN   Name=AREL1 {ECO:0000303|PubMed:23479728, ECO:0000312|HGNC:HGNC:20363};
GN   Synonyms=KIAA0317 {ECO:0000303|PubMed:9205841};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, INTERACTION WITH SEPTIN4; HTRA2 AND
RP   DIABLO, ACTIVE SITE, AUTOUBIQUITINATION, AND MUTAGENESIS OF CYS-790.
RX   PubMed=23479728; DOI=10.1074/jbc.m112.436113;
RA   Kim J.B., Kim S.Y., Kim B.M., Lee H., Kim I., Yun J., Jo Y., Oh T., Jo Y.,
RA   Chae H.D., Shin D.Y.;
RT   "Identification of a novel anti-apoptotic E3 ubiquitin ligase that
RT   ubiquitinates antagonists of inhibitor of apoptosis proteins SMAC, HtrA2,
RT   and ARTS.";
RL   J. Biol. Chem. 288:12014-12021(2013).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=25752577; DOI=10.1016/j.molcel.2015.01.042;
RA   Michel M.A., Elliott P.R., Swatek K.N., Simicek M., Pruneda J.N.,
RA   Wagstaff J.L., Freund S.M., Komander D.;
RT   "Assembly and specific recognition of K29- and K33-linked polyubiquitin.";
RL   Mol. Cell 58:95-109(2015).
RN   [8]
RP   FUNCTION, INTERACTION WITH SOCS2, AND CHARACTERIZATION OF VARIANT LEU-779.
RX   PubMed=31578312; DOI=10.1172/jci.insight.129110;
RA   Lear T.B., McKelvey A.C., Evankovich J.W., Rajbhandari S., Coon T.A.,
RA   Dunn S.R., Londino J.D., McVerry B.J., Zhang Y., Valenzi E., Burton C.L.,
RA   Gordon R., Gingras S., Lockwood K.C., Jurczak M.J., Lafyatis R.,
RA   Shlomchik M.J., Liu Y., Chen B.B.;
RT   "KIAA0317 regulates pulmonary inflammation through SOCS2 degradation.";
RL   JCI Insight 4:0-0(2019).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that catalyzes 'Lys-11'- or 'Lys-
CC       33'-linked polyubiquitin chains, with some preference for 'Lys-33'
CC       linkages (PubMed:25752577). E3 ubiquitin-protein ligases accept
CC       ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a
CC       thioester and then directly transfers the ubiquitin to targeted
CC       substrates (PubMed:23479728, PubMed:31578312). Ubiquitinates SEPTIN4,
CC       DIABLO/SMAC and HTRA2 in vitro (PubMed:23479728). Modulates pulmonary
CC       inflammation by targeting SOCS2 for ubiquitination and subsequent
CC       degradation by the proteasome (PubMed:31578312).
CC       {ECO:0000269|PubMed:23479728, ECO:0000269|PubMed:25752577,
CC       ECO:0000269|PubMed:31578312}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.26; Evidence={ECO:0000269|PubMed:23479728,
CC         ECO:0000269|PubMed:25752577};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000269|PubMed:23479728, ECO:0000269|PubMed:25752577}.
CC   -!- SUBUNIT: Interacts with SOCS2 (PubMed:31578312). Interacts (via HECT
CC       domain) with HTRA2, DIABLO/SMAC and SEPTIN4; in the cytoplasm following
CC       induction of apoptosis (PubMed:23479728). {ECO:0000269|PubMed:23479728,
CC       ECO:0000269|PubMed:31578312}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O15033-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O15033-2; Sequence=VSP_013259;
CC   -!- PTM: Autoubiquitinated in vitro in the presence of E2 enzyme
CC       UBE2D1/UBCH5A. {ECO:0000269|PubMed:23479728}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA20775.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB002315; BAA20775.2; ALT_INIT; mRNA.
DR   EMBL; AK304217; BAG65089.1; -; mRNA.
DR   EMBL; AC007956; AAF61276.1; -; Genomic_DNA.
DR   EMBL; CH471061; EAW81186.1; -; Genomic_DNA.
DR   EMBL; BC032944; AAH32944.1; -; mRNA.
DR   CCDS; CCDS41971.1; -. [O15033-1]
DR   RefSeq; NP_001034568.1; NM_001039479.2. [O15033-1]
DR   RefSeq; XP_011535717.1; XM_011537415.3. [O15033-1]
DR   RefSeq; XP_054233114.1; XM_054377139.1. [O15033-1]
DR   PDB; 6JX5; X-ray; 2.40 A; A/B/C=436-823.
DR   PDB; 6LOH; X-ray; 3.21 A; A/B/C=435-811.
DR   PDBsum; 6JX5; -.
DR   PDBsum; 6LOH; -.
DR   AlphaFoldDB; O15033; -.
DR   SMR; O15033; -.
DR   BioGRID; 115203; 42.
DR   FunCoup; O15033; 2825.
DR   IntAct; O15033; 20.
DR   STRING; 9606.ENSP00000348714; -.
DR   iPTMnet; O15033; -.
DR   PhosphoSitePlus; O15033; -.
DR   BioMuta; AREL1; -.
DR   jPOST; O15033; -.
DR   MassIVE; O15033; -.
DR   PaxDb; 9606-ENSP00000348714; -.
DR   PeptideAtlas; O15033; -.
DR   ProteomicsDB; 48389; -. [O15033-1]
DR   ProteomicsDB; 48390; -. [O15033-2]
DR   Antibodypedia; 25651; 65 antibodies from 17 providers.
DR   DNASU; 9870; -.
DR   Ensembl; ENST00000356357.9; ENSP00000348714.4; ENSG00000119682.19. [O15033-1]
DR   Ensembl; ENST00000681599.1; ENSP00000505623.1; ENSG00000119682.19. [O15033-1]
DR   GeneID; 9870; -.
DR   KEGG; hsa:9870; -.
DR   MANE-Select; ENST00000356357.9; ENSP00000348714.4; NM_001039479.2; NP_001034568.1.
DR   UCSC; uc001xqb.4; human. [O15033-1]
DR   AGR; HGNC:20363; -.
DR   ClinPGx; PA134985474; -.
DR   CTD; 9870; -.
DR   DisGeNET; 9870; -.
DR   GeneCards; AREL1; -.
DR   HGNC; HGNC:20363; AREL1.
DR   HPA; ENSG00000119682; Low tissue specificity.
DR   MalaCards; AREL1; -.
DR   MIM; 615380; gene.
DR   OpenTargets; ENSG00000119682; -.
DR   VEuPathDB; HostDB:ENSG00000119682; -.
DR   eggNOG; KOG0939; Eukaryota.
DR   GeneTree; ENSGT00940000156723; -.
DR   InParanoid; O15033; -.
DR   OMA; GHLCKDA; -.
DR   OrthoDB; 6057829at2759; -.
DR   PAN-GO; O15033; 5 GO annotations based on evolutionary models.
DR   PhylomeDB; O15033; -.
DR   BRENDA; 2.3.2.26; 2681.
DR   PathwayCommons; O15033; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; O15033; -.
DR   SIGNOR; O15033; -.
DR   UniPathway; UPA00143; -.
DR   Agora; ENSG00000119682; -.
DR   BioGRID-ORCS; 9870; 25 hits in 1192 CRISPR screens.
DR   ChiTaRS; AREL1; human.
DR   GenomeRNAi; 9870; -.
DR   Pharos; O15033; Tbio.
DR   PRO; PR:O15033; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; O15033; protein.
DR   Bgee; ENSG00000119682; Expressed in male germ line stem cell (sensu Vertebrata) in testis and 178 other cell types or tissues.
DR   ExpressionAtlas; O15033; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0070979; P:protein K11-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:1990390; P:protein K33-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   CDD; cd00078; HECTc; 1.
DR   FunFam; 2.60.40.10:FF:000330; Apoptosis resistant E3 ubiquitin protein ligase 1; 1.
DR   FunFam; 3.30.2160.10:FF:000008; Apoptosis-resistant E3 ubiquitin protein ligase 1; 1.
DR   FunFam; 3.30.2410.10:FF:000013; Apoptosis-resistant E3 ubiquitin protein ligase 1; 1.
DR   FunFam; 3.90.1750.10:FF:000013; Apoptosis-resistant E3 ubiquitin protein ligase 1; 1.
DR   Gene3D; 3.30.2160.10; Hect, E3 ligase catalytic domain; 1.
DR   Gene3D; 3.30.2410.10; Hect, E3 ligase catalytic domain; 1.
DR   Gene3D; 3.90.1750.10; Hect, E3 ligase catalytic domains; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   InterPro; IPR058906; AREL1_N.
DR   InterPro; IPR050409; E3_ubiq-protein_ligase.
DR   InterPro; IPR017868; Filamin/ABP280_repeat-like.
DR   InterPro; IPR000569; HECT_dom.
DR   InterPro; IPR035983; Hect_E3_ubiquitin_ligase.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR058738; PH-like_AREL1.
DR   PANTHER; PTHR11254:SF340; APOPTOSIS-RESISTANT E3 UBIQUITIN PROTEIN LIGASE 1; 1.
DR   PANTHER; PTHR11254; HECT DOMAIN UBIQUITIN-PROTEIN LIGASE; 1.
DR   Pfam; PF25915; AREL1_N; 1.
DR   Pfam; PF25916; AREL1_PH-like; 1.
DR   Pfam; PF00630; Filamin; 1.
DR   Pfam; PF00632; HECT; 1.
DR   SMART; SM00119; HECTc; 1.
DR   SUPFAM; SSF81296; E set domains; 1.
DR   SUPFAM; SSF56204; Hect, E3 ligase catalytic domain; 1.
DR   PROSITE; PS50194; FILAMIN_REPEAT; 1.
DR   PROSITE; PS50237; HECT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; Proteomics identification;
KW   Reference proteome; Transferase; Ubl conjugation; Ubl conjugation pathway.
FT   CHAIN           1..823
FT                   /note="Apoptosis-resistant E3 ubiquitin protein ligase 1"
FT                   /id="PRO_0000120349"
FT   REPEAT          52..158
FT                   /note="Filamin"
FT   DOMAIN          483..823
FT                   /note="HECT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00104"
FT   REGION          315..345
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          483..789
FT                   /note="Interaction with SOCS2"
FT                   /evidence="ECO:0000269|PubMed:31578312"
FT   ACT_SITE        790
FT                   /note="Glycyl thioester intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00104,
FT                   ECO:0000269|PubMed:23479728"
FT   VAR_SEQ         790..823
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_013259"
FT   VARIANT         779
FT                   /note="P -> L (loss of interaction with SOCS2;
FT                   dbSNP:rs371610162)"
FT                   /evidence="ECO:0000269|PubMed:31578312"
FT                   /id="VAR_083342"
FT   MUTAGEN         790
FT                   /note="C->A: Failure to form ubiquitin thioester complex."
FT                   /evidence="ECO:0000269|PubMed:23479728"
FT   CONFLICT        114
FT                   /note="T -> N (in Ref. 5; AAH32944)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        373
FT                   /note="P -> H (in Ref. 5; AAH32944)"
FT                   /evidence="ECO:0000305"
FT   HELIX           439..453
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   TURN            454..456
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   STRAND          461..466
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           471..478
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   TURN            479..481
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           485..488
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   STRAND          489..495
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   STRAND          500..503
FT                   /evidence="ECO:0007829|PDB:6LOH"
FT   HELIX           504..519
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   STRAND          524..531
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   STRAND          533..535
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   STRAND          537..539
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           550..567
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           570..572
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           582..589
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           597..601
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           603..615
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   TURN            619..621
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   STRAND          624..630
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   STRAND          632..634
FT                   /evidence="ECO:0007829|PDB:6LOH"
FT   STRAND          636..643
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           646..648
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   TURN            653..655
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           656..668
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           670..672
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           673..686
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           689..692
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           697..705
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           712..718
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   STRAND          720..723
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           726..730
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           732..742
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           745..756
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   STRAND          757..760
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           765..768
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   STRAND          774..782
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   STRAND          786..788
FT                   /evidence="ECO:0007829|PDB:6LOH"
FT   HELIX           789..791
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   STRAND          794..798
FT                   /evidence="ECO:0007829|PDB:6JX5"
FT   HELIX           802..812
FT                   /evidence="ECO:0007829|PDB:6JX5"
SQ   SEQUENCE   823 AA;  94223 MW;  9E26273B529DB477 CRC64;
     MFYVIGGITV SVVAFFFTIK FLFELAARVV SFLQNEDRER RGDRTIYDYV RGNYLDPRSC
     KVSWDWKDPY EVGHSMAFRV HLFYKNGQPF PAHRPVGLRV HISHVELAVE IPVTQEVLQE
     PNSNVVKVAF TVRKAGRYEI TVKLGGLNVA YSPYYKIFQP GMVVPSKTKI VCHFSTLVLT
     CGQPHTLQIV PRDEYDNPTN NSMSLRDEHN YTLSIHELGP QEEESTGVSF EKSVTSNRQT
     FQVFLRLTLH SRGCFHACIS YQNQPINNGE FDIIVLSEDE KNIVERNVST SGVSIYFEAY
     LYNATNCSST PWHLPPMHMT SSQRRPSTAV DEEDEDSPSE CHTPEKVKKP KKVYCYVSPK
     QFSVKEFYLK IIPWRLYTFR VCPGTKFSYL GPDPVHKLLT LVVDDGIQPP VELSCKERNI
     LAATFIRSLH KNIGGSETFQ DKVNFFQREL RQVHMKRPHS KVTLKVSRHA LLESSLKATR
     NFSISDWSKN FEVVFQDEEA LDWGGPRREW FELICKALFD TTNQLFTRFS DNNQALVHPN
     PNRPAHLRLK MYEFAGRLVG KCLYESSLGG AYKQLVRARF TRSFLAQIIG LRMHYKYFET
     DDPEFYKSKV CFILNNDMSE MELVFAEEKY NKSGQLDKVV ELMTGGAQTP VTNANKIFYL
     NLLAQYRLAS QVKEEVEHFL KGLNELVPEN LLAIFDENEL ELLMCGTGDI SVSDFKAHAV
     VVGGSWHFRE KVMRWFWTVV SSLTQEELAR LLQFTTGSSQ LPPGGFAALC PSFQIIAAPT
     HSTLPTAHTC FNQLCLPTYD SYEEVHRMLQ LAISEGCEGF GML
//
